Suchergebnisse - "Saccon, Francesca"

PubPharm (35)

1

Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis : A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry

enthalten in: Journal of scleroderma and related disorders | 2024

von Riccieri, V. | Pellegrino, G. | Cipolletta, E. | +66

2

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

enthalten in: Journal of translational autoimmunity | 2023

von Ferri, C. | Raimondo, V. | Giuggioli, D. | +71

3

Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations : Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)

enthalten in: Journal of personalized medicine | 2023

von Zen, M. | Gatto, M. | Depascale, R. | +51

4

Correction to: Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Zen, M. | Fuzzi, E. | Loredo Martinez, M. | +7

ErratumFor: Rheumatology (Oxford). 2022 Feb 2;61(2):688-695. - PMID 33909900

5

Physician's global assessment is often useful in SLE, but not always : the case of clinical remission

enthalten in: Annals of the rheumatic diseases | 2022

von Zen, M. | Saccon, F. | Gatto, M. | +1

CommentOn: Ann Rheum Dis. 2020 Jun;79(6):787-792. - PMID 32241797

6

Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis

enthalten in: Lupus science & medicine | 2022

von Gatto, M. | Radice, F. | Saccon, F. | +13

7

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Zen, M. | Fuzzi, E. | Loredo Martinez, M. | +7

ErratumIn: Rheumatology (Oxford). 2022 Aug 3;61(8):3506. - PMID 35217855

8

Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort

enthalten in: Journal of autoimmunity | 2021

von Gatto, M. | Saccon, F. | Andreoli, L. | +42

9

Belimumab : a step forward in the treatment of systemic lupus erythematosus

enthalten in: Expert opinion on biological therapy | 2021

von Depascale, R. | Gatto, M. | Zen, M. | +6

10

Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis : 8 years follow up

enthalten in: Journal of nephrology | 2021

von Argolini, L. | Frontini, G. | Elefante, E. | +13